Biosimilars: Overview of Legislation, Policy, and Current State of Implementation

Published on: 

Enduring Webcast: Biosimilars: Overview of Legislation, Policy and Current State of Implementation

This webcast was brought to you by Amgen.


The faculty for this webcast:

  • Defined therapeutic equivalence for small molecule generics
  • Described how biologics differ from small molecule drugs
  • Explained how the Biologics Price Control and Innovation Act amends the Public Health Service Act and the key requirements of the US biosimilars pathway
  • Discussed the difference between biosimilarity and interchangeability
  • Reviewed the US legislation for intellectual property and payment provisions

Length of webcast: 14 minutes

System Requirements

PC-based attendees

Required: Windows® 7, Vista, XP, 2003 Server or 2000

Macintosh®-based attendees

Required: Mac OS® X 10.4.11 (Tiger®) or newer